31. Downing S, Chien MB, Kass PH, et al. Prevalence and importance of internal tandem duplications in exons 11 and 12 of c-kit
in mast cell tumors of dogs. Am J Vet Res 2002;63(12):1718–1723.
32. Webster JD, Yuzbasiyan-Gurkan V, Miller RA, et al. Cellular proliferation in canine cutaneous mast cell tumors: associations
with c-KIT and its role in prognostication. Vet Pathol 2007;44(3):298–308.
33. Gleixner KV, Rebuzzi L, Mayerhofer M, et al. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic
canine mast cells. Exp Hematol 2007;35(10):1510-1521.
34. al-Sarraf R, Mauldin GN, Patnaik AK, et al. A prospective study of radiation therapy for the treatment of grade 2 mast cell
tumors in 32 dogs. J Vet Intern Med 1996;10(6):376-378.
35. Frimberger AE, Moore AS, LaRue SM, et al. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors
in the dog: 37 cases (1989-1993). J Am Anim Hosp Assoc 1997;33(4):320-324.
36. Poirier VJ, Adams WM, Forrest, LJ, et al. Radiation therapy for incompletely excised grade II canine mast cell tumors. J Am Anim Hosp Assoc 2006;42(6):430-434.
37. Chaffin K, Thrall DE. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Vet Radiol Ultrasound 2002;43(4):392-395.
38. Dobson J, Cohen S, Gould S. Treatment of canine mast cell tumours with prednisolone and radiotherapy. Vet Comp Oncol 2004;2(3):132-141.
39. Carlsten KS, London CA, Haney S, et al. Multicenter prospective trial of hypofractionated radiation treatment, toceranib,
and prednisone for measurable canine mast cell tumors. J Vet Intern Med 2012;26(1):135-141.
40. Elmslie R. Combination chemotherapy with and without surgery for dogs with high-grade mast cell tumors with regional lymph
node metastases. Vet Cancer Soc Newsl 1997;20:6-7.
41. Gerritsen RJ, Teske E, Kraus JS, et al. Multiagent chemotherapy for mast cell tumours in the dog. Vet Q 1998;20:28-31.
42. Rassnick KM, Bailey DB, Russell DS, et al. A phase II study to evaluate the toxicity and efficacy of alternating CCNU and
high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours.
Vet Comp Oncol 2010;8(2):138-152.
43. Taylor F, Gear R, Hoather T, et al. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours:
21 cases. J Small Anim Pract 2009;50(6):284-289.
44. Rassnick KM, Al-Sarraf R, Bailey DB, et al. Phase II open-label study of single-agent hydroxyurea for treatment of mast cell
tumours in dogs. Vet Comp Oncol 2010;8(2):103-111.
45. McCaw DL, Miller MA, Ogilvie GK, et al. Response of canine mast cell tumors to treatment with oral prednisone. J Vet Intern Med 1994;8(6):406-408.
46. Rassnick KM, Bailey DB, Flory AB, et al. Efficacy of vinblastine for treatment of canine mast cell tumors. J Vet Intern Med 2008;22(6):1390-1396.
47. Grant IA, Rodriguez CO, Kent MS, et al. A phase II clinical trial of vinorelbine in dogs with cutaneous mast cell tumors.
J Vet Intern Med 2008;22(2):388-393.
48. McCaw DL, Miller MA, Bergman PJ, et al. Vincristine therapy for mast cell tumors in dogs. J Vet Intern Med 1997;11(6):375-378.
|
Featuring Information from:
